Highbridge Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-24,522
| Closed | -$352K | – | 768 |
|
|
2017
Q2 | $352K | Sell |
24,522
-15,654
| -39% | -$225K | 0.01% | 636 |
|
|
2017
Q1 | $370K | Sell |
40,176
-11,767
| -23% | -$108K | 0.01% | 813 |
|
|
2016
Q4 | $541K | Buy |
51,943
+30,357
| +141% | +$316K | 0.01% | 625 |
|
|
2016
Q3 | $195K | Buy |
+21,586
| New | +$195K | ﹤0.01% | 933 |
|
|
2016
Q2 | – | Sell |
-17,837
| Closed | -$161K | – | 1029 |
|
|
2016
Q1 | $161K | Buy |
17,837
+4,006
| +29% | +$36.2K | ﹤0.01% | 739 |
|
|
2015
Q4 | $179K | Sell |
13,831
-49,185
| -78% | -$637K | ﹤0.01% | 747 |
|
|
2015
Q3 | $609K | Buy |
+63,016
| New | +$609K | 0.01% | 600 |
|